Alchemab, Therapeutics

Alchemab Therapeutics enters into collaboration with Lilly to discover, research and develop novel therapies for ALS

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Alchemab Therapeutics United Kingdom United States of America

en | CA7609751028 | ALCHEMAB | boerse | 67990138 |